
REV Group, Inc.
REVGNYSEIndustrials
$63.90
$-1.30(-1.99%)
Market Cap$3.1B
P/E Ratio—
52W High$69.915
52W Low$26.51
REV Group, Inc.(REVG)· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。
FMP · REVG · 截至 2026-06-08
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-10 | 2024-10 | 2023-10 | 2022-10 | 2021-10 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $2.46B | $2.38B | $2.64B | $2.33B | $2.38B |
| Cost of Revenue | $2.09B | $2.08B | $2.32B | $2.08B | $2.09B |
| Gross Profit | $0.37B | $0.30B | $0.32B | $0.25B | $0.29B |
| Gross Margin %(computed) | 15.01% | 12.49% | 11.98% | 10.62% | 12.22% |
| Operating Expenses | |||||
| R&D Expenses | $0.01B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.00B | $0.18B | $0.20B | $0.18B | $0.18B |
| Total Operating Expenses | $0.19B | $0.22B | $0.23B | $0.21B | $0.21B |
| Operating Income | $0.19B | $0.08B | $0.09B | $0.04B | $0.08B |
| Operating Margin %(computed) | 7.83% | 3.34% | 3.36% | 1.58% | 3.52% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.03B | $0.03B | $0.03B | $0.02B | $0.02B |
| Income Before Tax | $0.12B | $0.34B | $0.06B | $0.02B | $0.06B |
| Income Tax Expense | $0.02B | $0.08B | $0.01B | $0.00B | $0.01B |
| Net Income | $0.10B | $0.26B | $0.05B | $0.02B | $0.04B |
| Net Margin %(computed) | 3.86% | 10.82% | 1.72% | 0.65% | 1.86% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $1.92 | $4.79 | $0.77 | $0.25 | $0.70 |
| Wtd Avg Shares | 0.05B | 0.05B | 0.06B | 0.06B | 0.06B |
| EBITDA | $0.17B | $0.39B | $0.11B | $0.07B | $0.12B |
| EBITDA Margin %(computed) | 6.84% | 16.57% | 4.28% | 2.96% | 5.04% |
数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · B
深入了解REV Group, Inc.
关于REV Group, Inc.(REVG)损益表
REV Group, Inc.(REVG)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,REVG实现营收$2.46B,毛利润$0.37B(毛利率15.01%),净利润$0.10B(净利率3.86%)。
常见问题
REVG · 4 问REV Group, Inc.(REVG)2025财年营收为$2.46B,同比up3.5%。
REVG revenueREVG salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08